Medtronic plc (MDT)
USD 82.9
(0.44%)
USD 82.9
(0.44%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 24.76 Billion USD | 8.51% |
| 2023 | 22.82 Billion USD | 11.87% |
| 2022 | 20.4 Billion USD | -10.51% |
| 2021 | 22.79 Billion USD | 10.35% |
| 2020 | 20.65 Billion USD | -1.31% |
| 2019 | 20.93 Billion USD | -5.24% |
| 2018 | 22.08 Billion USD | -22.43% |
| 2017 | 28.47 Billion USD | 0.39% |
| 2016 | 28.36 Billion USD | -9.5% |
| 2015 | 31.34 Billion USD | 197.8% |
| 2014 | 10.52 Billion USD | 8.88% |
| 2013 | 9.66 Billion USD | 3.0% |
| 2012 | 9.38 Billion USD | 11.03% |
| 2011 | 8.45 Billion USD | 4.11% |
| 2010 | 8.11 Billion USD | 34.8% |
| 2009 | 6.02 Billion USD | 2.15% |
| 2008 | 5.89 Billion USD | 22.05% |
| 2007 | 4.83 Billion USD | -1.98% |
| 2006 | 4.92 Billion USD | 2144.44% |
| 2005 | 219.6 Million USD | -71.32% |
| 2004 | 765.6 Million USD | -14.51% |
| 2003 | 895.5 Million USD | -57.66% |
| 2002 | 2.11 Billion USD | 342.65% |
| 2001 | -871.6 Million USD | -638.64% |
| 2000 | -118 Million USD | -440.06% |
| 1999 | 34.7 Million USD | 112.7% |
| 1998 | -273.2 Million USD | -254.81% |
| 1997 | -77 Million USD | -123.19% |
| 1996 | -34.5 Million USD | 31.82% |
| 1995 | -50.6 Million USD | -67.0% |
| 1994 | -30.3 Million USD | -217.44% |
| 1993 | 25.8 Million USD | 322.41% |
| 1992 | -11.6 Million USD | -216.0% |
| 1991 | 10 Million USD | -82.79% |
| 1990 | 58.1 Million USD | 103.15% |
| 1989 | 28.6 Million USD | 253.76% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 23.76 Billion USD | 0.53% |
| 2024 Q1 | 23.64 Billion USD | 3.6% |
| 2024 FY | 24.76 Billion USD | 8.51% |
| 2024 Q3 | 23.55 Billion USD | -0.88% |
| 2024 Q4 | 24.76 Billion USD | 5.11% |
| 2023 FY | 22.82 Billion USD | 11.87% |
| 2023 Q4 | 22.82 Billion USD | -3.33% |
| 2023 Q2 | 21.73 Billion USD | 3.15% |
| 2023 Q1 | 21.07 Billion USD | -0.94% |
| 2023 Q3 | 23.6 Billion USD | 8.62% |
| 2022 FY | 20.4 Billion USD | -10.51% |
| 2022 Q2 | 22.72 Billion USD | -1.03% |
| 2022 Q3 | 21.67 Billion USD | -4.61% |
| 2022 Q4 | 21.27 Billion USD | -1.87% |
| 2022 Q1 | 22.96 Billion USD | 0.72% |
| 2021 Q3 | 25.24 Billion USD | 7.03% |
| 2021 Q1 | 22.19 Billion USD | 7.43% |
| 2021 Q4 | 22.79 Billion USD | -9.7% |
| 2021 FY | 22.79 Billion USD | 10.35% |
| 2021 Q2 | 23.58 Billion USD | 6.3% |
| 2020 Q1 | 21.18 Billion USD | 1.2% |
| 2020 Q3 | 21.86 Billion USD | 0.93% |
| 2020 Q2 | 21.66 Billion USD | 2.28% |
| 2020 FY | 20.65 Billion USD | -1.31% |
| 2020 Q4 | 20.65 Billion USD | -5.53% |
| 2019 Q3 | 21.32 Billion USD | 1.05% |
| 2019 Q2 | 21.1 Billion USD | 1.26% |
| 2019 Q1 | 20.84 Billion USD | -5.64% |
| 2019 Q4 | 20.93 Billion USD | -1.86% |
| 2019 FY | 20.93 Billion USD | -5.24% |
| 2018 Q3 | 22.46 Billion USD | -4.59% |
| 2018 FY | 22.08 Billion USD | -22.43% |
| 2018 Q2 | 23.54 Billion USD | -19.7% |
| 2018 Q4 | 22.08 Billion USD | -1.67% |
| 2018 Q1 | 29.32 Billion USD | 2.97% |
| 2017 Q4 | 28.47 Billion USD | -3.09% |
| 2017 FY | 28.47 Billion USD | 0.39% |
| 2017 Q3 | 29.38 Billion USD | -0.14% |
| 2017 Q2 | 29.42 Billion USD | 1.42% |
| 2017 Q1 | 29.01 Billion USD | 2.28% |
| 2016 Q2 | 33.47 Billion USD | 2.73% |
| 2016 Q3 | 33.11 Billion USD | -1.07% |
| 2016 Q4 | 28.36 Billion USD | -14.34% |
| 2016 FY | 28.36 Billion USD | -9.5% |
| 2016 Q1 | 32.58 Billion USD | 3.95% |
| 2015 Q3 | 11.51 Billion USD | -7.1% |
| 2015 Q2 | 12.39 Billion USD | 8.09% |
| 2015 Q1 | 11.46 Billion USD | 8.92% |
| 2015 FY | 31.34 Billion USD | 197.8% |
| 2015 Q4 | 31.34 Billion USD | 172.29% |
| 2014 Q1 | 10.42 Billion USD | 7.84% |
| 2014 Q4 | 10.52 Billion USD | -3.57% |
| 2014 Q3 | 10.91 Billion USD | -2.7% |
| 2014 FY | 10.52 Billion USD | 8.88% |
| 2014 Q2 | 11.21 Billion USD | 7.61% |
| 2013 Q3 | 10.12 Billion USD | 4.41% |
| 2013 Q4 | 9.66 Billion USD | -4.48% |
| 2013 Q1 | 9.91 Billion USD | 5.66% |
| 2013 Q2 | 9.69 Billion USD | -2.25% |
| 2013 FY | 9.66 Billion USD | 3.0% |
| 2012 Q1 | 8.65 Billion USD | 2.44% |
| 2012 Q3 | 9.03 Billion USD | -2.1% |
| 2012 Q4 | 9.38 Billion USD | 3.93% |
| 2012 FY | 9.38 Billion USD | 11.03% |
| 2012 Q2 | 9.22 Billion USD | 6.53% |
| 2011 Q2 | 9.3 Billion USD | 1.8% |
| 2011 Q1 | 9.14 Billion USD | 12.62% |
| 2011 FY | 8.45 Billion USD | 4.11% |
| 2011 Q4 | 8.45 Billion USD | -10.79% |
| 2011 Q3 | 9.47 Billion USD | 1.78% |
| 2010 Q2 | 6.67 Billion USD | 12.23% |
| 2010 FY | 8.11 Billion USD | 34.8% |
| 2010 Q1 | 5.94 Billion USD | -1.33% |
| 2010 Q4 | 8.11 Billion USD | 36.16% |
| 2010 Q3 | 5.96 Billion USD | -10.6% |
| 2009 Q2 | 6 Billion USD | 0.6% |
| 2009 Q4 | 6.02 Billion USD | 11.0% |
| 2009 Q3 | 5.42 Billion USD | -9.57% |
| 2009 Q1 | 5.96 Billion USD | 1.15% |
| 2009 FY | 6.02 Billion USD | 2.15% |
| 2008 Q3 | 6.24 Billion USD | 269.96% |
| 2008 FY | 5.89 Billion USD | 22.05% |
| 2008 Q1 | 5.16 Billion USD | 6.93% |
| 2008 Q4 | 5.89 Billion USD | -5.59% |
| 2008 Q2 | 1.68 Billion USD | -67.32% |
| 2007 FY | 4.83 Billion USD | -1.98% |
| 2007 Q3 | 4.04 Billion USD | -19.5% |
| 2007 Q4 | 4.83 Billion USD | 19.55% |
| 2007 Q2 | 5.02 Billion USD | -22.96% |
| 2007 Q1 | 6.51 Billion USD | 32.2% |
| 2006 Q3 | 2.65 Billion USD | 40.74% |
| 2006 Q1 | 1.84 Billion USD | 739.07% |
| 2006 Q2 | 1.88 Billion USD | 2.49% |
| 2006 FY | 4.92 Billion USD | 2144.44% |
| 2006 Q4 | 4.92 Billion USD | 85.44% |
| 2005 Q2 | 68.1 Million USD | -65.97% |
| 2005 Q1 | 200.1 Million USD | -73.86% |
| 2005 FY | 219.6 Million USD | -71.32% |
| 2005 Q3 | 203.1 Million USD | 198.24% |
| 2005 Q4 | 219.6 Million USD | 8.12% |
| 2004 FY | 765.6 Million USD | -14.51% |
| 2004 Q1 | 1.21 Billion USD | 35.68% |
| 2004 Q2 | 1.49 Billion USD | 23.06% |
| 2004 Q3 | 1.19 Billion USD | -19.85% |
| 2004 Q4 | 765.6 Million USD | -36.11% |
| 2003 FY | 895.5 Million USD | -57.66% |
| 2003 Q2 | 1.39 Billion USD | -15.1% |
| 2003 Q3 | 935.1 Million USD | -33.09% |
| 2003 Q4 | 895.5 Million USD | -4.23% |
| 2003 Q1 | 1.64 Billion USD | -22.17% |
| 2002 Q2 | 2.01 Billion USD | 295.77% |
| 2002 FY | 2.11 Billion USD | 342.65% |
| 2002 Q4 | 2.11 Billion USD | 10.19% |
| 2002 Q3 | 1.91 Billion USD | -4.66% |
| 2002 Q1 | -1.02 Billion USD | -17.99% |
| 2001 Q3 | -281 Million USD | 21.44% |
| 2001 Q4 | -871.6 Million USD | -210.18% |
| 2001 Q1 | -306.8 Million USD | -160.0% |
| 2001 Q2 | -357.7 Million USD | -16.59% |
| 2001 FY | -871.6 Million USD | -638.64% |
| 2000 Q1 | -22.6 Million USD | -165.13% |
| 2000 FY | -118 Million USD | -440.06% |
| 2000 Q2 | 46.5 Million USD | 305.75% |
| 2000 Q3 | 162.8 Million USD | 250.11% |
| 2000 Q4 | -118 Million USD | -172.48% |
| 1999 FY | 34.7 Million USD | 112.7% |
| 1999 Q3 | -98.7 Million USD | 71.92% |
| 1999 Q1 | -143.6 Million USD | 47.44% |
| 1999 Q2 | -351.5 Million USD | -144.78% |
| 1999 Q4 | 34.7 Million USD | 135.16% |
| 1998 Q2 | -181.7 Million USD | -9.33% |
| 1998 Q1 | -166.2 Million USD | -115.84% |
| 1998 Q3 | -200.7 Million USD | -10.46% |
| 1998 FY | -273.2 Million USD | -254.81% |
| 1998 Q4 | -273.2 Million USD | -36.12% |
| 1997 FY | -77 Million USD | -123.19% |
| 1997 Q3 | 43.8 Million USD | 346.94% |
| 1997 Q4 | -77 Million USD | -275.8% |
| 1997 Q2 | 9.8 Million USD | 117.85% |
| 1997 Q1 | -54.9 Million USD | -59.13% |
| 1996 FY | -34.5 Million USD | 31.82% |
| 1996 Q2 | -102.1 Million USD | -2.51% |
| 1996 Q3 | -89.6 Million USD | 12.24% |
| 1996 Q4 | -34.5 Million USD | 61.5% |
| 1996 Q1 | -99.6 Million USD | -96.84% |
| 1995 Q1 | 15.8 Million USD | 152.15% |
| 1995 FY | -50.6 Million USD | -67.0% |
| 1995 Q2 | -87.1 Million USD | -651.27% |
| 1995 Q3 | -91.2 Million USD | -4.71% |
| 1995 Q4 | -50.6 Million USD | 44.52% |
| 1994 Q2 | -40.9 Million USD | -50.92% |
| 1994 FY | -30.3 Million USD | -217.44% |
| 1994 Q4 | -30.3 Million USD | 66.81% |
| 1994 Q1 | -27.1 Million USD | -205.04% |
| 1994 Q3 | -91.3 Million USD | -123.23% |
| 1993 Q4 | 25.8 Million USD | 128.99% |
| 1993 Q3 | -89 Million USD | 0.45% |
| 1993 Q2 | -89.4 Million USD | -445.12% |
| 1993 Q1 | -16.4 Million USD | -41.38% |
| 1993 FY | 25.8 Million USD | 322.41% |
| 1992 Q1 | 15.1 Million USD | 51.0% |
| 1992 Q4 | -11.6 Million USD | -1260.0% |
| 1992 Q3 | 1 Million USD | -93.15% |
| 1992 FY | -11.6 Million USD | -216.0% |
| 1992 Q2 | 14.6 Million USD | -3.31% |
| 1991 Q2 | -57.7 Million USD | -3.22% |
| 1991 Q1 | -55.9 Million USD | -196.21% |
| 1991 FY | 10 Million USD | -82.79% |
| 1991 Q4 | 10 Million USD | 114.03% |
| 1991 Q3 | -71.3 Million USD | -23.57% |
| 1990 FY | 58.1 Million USD | 103.15% |
| 1990 Q4 | 58.1 Million USD | 336.18% |
| 1990 Q3 | -24.6 Million USD | 15.75% |
| 1990 Q2 | -29.2 Million USD | 0.0% |
| 1989 FY | 28.6 Million USD | 253.76% |
| 1989 Q4 | 28.6 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Abbott Laboratories | 8.97 Billion USD | -175.849% |
| Allurion Technologies Inc. | 3.82 Million USD | -648146.073% |
| Artivion, Inc. | 300.4 Million USD | -8143.315% |
| Avanos Medical, Inc. | 121.4 Million USD | -20297.858% |
| Butterfly Network, Inc. | -109.6 Million USD | 22692.123% |
| Butterfly Network, Inc. | -109.6 Million USD | 22692.123% |
| Bio-Rad Laboratories, Inc. | 1 Billion USD | -2371.532% |
| Boston Scientific Corporation | 8.62 Billion USD | -187.041% |
| CONMED Corporation | 966.95 Million USD | -2460.918% |
| Edwards Lifesciences Corporation | -449.1 Million USD | 5613.917% |
| Paragon 28, Inc. | 36.39 Million USD | -67947.045% |
| Glaukos Corporation | 290.27 Million USD | -8430.993% |
| Globus Medical, Inc. | 53.11 Million USD | -46524.115% |
| Inspire Medical Systems, Inc. | -160.69 Million USD | 15510.322% |
| Integer Holdings Corporation | 1.01 Billion USD | -2334.232% |
| Myomo, Inc. | -6.27 Million USD | 395043.99% |
| Nevro Corp. | 117.61 Million USD | -20955.182% |
| Owlet, Inc. | -1.34 Million USD | 1846708.387% |
| Penumbra, Inc. | 66.85 Million USD | -36938.754% |
| Vicarious Surgical Inc. | -37.99 Million USD | 65282.943% |
| Smith & Nephew plc | 2.78 Billion USD | -790.115% |
| Sonendo, Inc. | 26.34 Million USD | -93905.77% |
| STERIS plc | 3.17 Billion USD | -679.655% |
| Stryker Corporation | 10.02 Billion USD | -147.037% |
| Vapotherm, Inc. | 102.66 Million USD | -24019.727% |
| Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | -343.829% |